Harvard Bioscience EBITDA 2010-2025 | HBIO

Harvard Bioscience ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Harvard Bioscience Annual EBITDA
(Millions of US $)
2024 $1
2023 $9
2022 $1
2021 $10
2020 $9
2019 $8
2018 $9
2017 $3
2016 $1
2015 $3
2014 $11
2013 $6
2012 $12
2011 $13
2010 $14
2009 $12
Harvard Bioscience Quarterly EBITDA
(Millions of US $)
2025-03-31 $0
2024-12-31 $2
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $2
2023-09-30 $1
2023-06-30 $3
2023-03-31 $4
2022-12-31 $2
2022-09-30 $-2
2022-06-30 $6
2022-03-31 $-5
2021-12-31 $4
2021-09-30 $2
2021-06-30 $2
2021-03-31 $2
2020-12-31 $6
2020-09-30 $2
2020-06-30 $3
2020-03-31 $-1
2019-12-31 $4
2019-09-30 $1
2019-06-30 $2
2019-03-31 $2
2018-12-31 $4
2018-09-30 $3
2018-06-30 $2
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $1
2017-03-31 $1
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $1
2015-12-31 $1
2015-09-30 $0
2015-06-30 $1
2015-03-31 $0
2014-12-31 $3
2014-09-30 $2
2014-06-30 $3
2014-03-31 $2
2013-12-31 $0
2013-09-30 $1
2013-06-30 $2
2013-03-31 $2
2012-12-31 $6
2012-09-30 $1
2012-06-30 $2
2012-03-31 $2
2011-12-31 $5
2011-09-30 $1
2011-06-30 $4
2011-03-31 $3
2010-12-31 $4
2010-09-30 $3
2010-06-30 $3
2010-03-31 $4
2009-12-31 $4
2009-09-30 $3
2009-06-30 $2
2009-03-31 $3
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.016B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.870B 16.49
Kewaunee Scientific (KEQU) United States $0.107B 7.53